{"id":131087,"date":"2017-07-26T11:40:08","date_gmt":"2017-07-26T11:40:08","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=131087"},"modified":"2017-07-26T11:40:08","modified_gmt":"2017-07-26T11:40:08","slug":"high-intensity-focused-ultrasound-hifu-product-analysis","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/high-intensity-focused-ultrasound-hifu-product-analysis_131087.html","title":{"rendered":"High Intensity Focused Ultrasound (HIFU) Product Analysis"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/07\/1501048474.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/07\/1501048474.jpeg\" alt=\"\" width=\"180\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Till date more than 100,000 patients have been treated with HIFU therapeutic technology; nearly 25,000 patients alone treated in 2015.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">High-Intensity Focused Ultrasound (HIFU) is an FDA-approved, minimally invasive therapeutic technology with the potential to transform the treatment of many medical disorders by using ultrasonic energy to target tissue. Till date more than 100,000 patients have been treated with HIFU therapeutic technology; nearly 25,000 patients alone treated in 2015. <\/div>\n<p style=\"text-align: justify;\">Cancer treatment is an important issue in not only developed countries but developing and low-income countries too. High intensity focused ultrasound (HIFU) is a FDA-approved, minimally invasive therapeutic treatment that aims to kill cancer cells with high-frequency sound waves. <strong>More than 100,000 cancer patients have been treated with this technology globally<\/strong>. Our research report title &#8220;<a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/high-intensity-focused-ultrasound-hifu-product-analysis-of-20-manufacturers-and-deals-1093-p.php\" target=\"_blank\">High Intensity Focused Ultrasound (HIFU) Product Analysis<\/a><strong> of 20 Manufacturers &amp; Deals<\/strong>&rdquo; has been studied from 5 viewpoints:<\/p>\n<p style=\"text-align: justify;\">&bull; HIFU Products<\/p>\n<p style=\"text-align: justify;\">&bull; HIFU Patents and Intellectual Property<\/p>\n<p style=\"text-align: justify;\">&bull; HIFU Clinical &amp; Regulatory Status<\/p>\n<p style=\"text-align: justify;\">&bull; Companies HIFU Revenue<\/p>\n<p style=\"text-align: justify;\">&bull; Latest Development in High Intensity Focus Ultrasound (HIFU)<\/p>\n<p style=\"text-align: justify;\">&bull; Company HIFU Product covered (EDAP TMS, Sonacare Medical, Haifu, Insightec, Theraclion, Alpinion, Shanghai A&amp;S Co., LTD, Mianyang Sonic Electronic Ltd, Eye Tech Care, FUS Instruments, Image Guided Therapy, Philips Healthcare, Profound Medical Corp, Promedica Bioelectronics, Shenzhen PRO-HIFU Medical Tech. Co., Ltd., Shenzhen Wikkon, Sonic Concepts, Verasonics, Changjiangyuan Technology Development Co., Ltd, EpiSonica)<\/p>\n<p style=\"text-align: justify;\"><strong>Get Free 10% Customization in this Report<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Click here for summary of the report with TOC: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/high-intensity-focused-ultrasound-hifu-product-analysis-of-20-manufacturers-and-deals-1093-p.php\" target=\"_blank\">http:\/\/www.renub.com\/high-intensity-focused-ultrasound-hifu-product-analysis-of-20-manufacturers-and-deals-1093-p.php<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Steadily Growing Cancer Cases Globally<\/strong><\/p>\n<p style=\"text-align: justify;\">Cancer is one of the leading causes of death worldwide. <strong>In 2012, more than 14 Million new cases were identifying which is expected to increase to 22 Million within the next two decades.<\/strong> Africa, Asia, and Central and South America have generated more than 60 percent of new cases. The Most common cancers occurring are lung, female breast, bowel and prostate cancer globally.<\/p>\n<p style=\"text-align: justify;\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/uploads\/c7d70dab91e64cdb5c8f40cbb229808f.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\">View more reports about <strong>Medical Devices<\/strong> category by Renub Research at: <a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/medical-devices-15-c.php\" target=\"_blank\">http:\/\/www.renub.com\/medical-devices-15-c.php<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>High Intensity Focused Ultrasound (HIFU) can Treat Almost All Types of Cancer Patients<\/strong><\/p>\n<p style=\"text-align: justify;\">High Intensity Focused Ultrasound (HIFU) can treat almost all types of cancer patients such as prostate cancer, breast cancer, liver cancer, kidney cancer, pancreatic cancer, primary and secondary bone malignancy, brain tumor etc. The treatment of prostate cancer is dependent on stage, Gleason score, PSA level and patient age.<\/p>\n<p style=\"text-align: justify;\"><strong>HIFU is Commercially Approved Most Part of the World<\/strong><\/p>\n<p style=\"text-align: justify;\">HIFU manufacturers need to take approval for their HIFU product in respective country regulatory authorities where they want its commercial launch. Country Regulatory authorities check listed HIFU products on the basis of several parameters and when they found that product is safe or does not have any side effects then it approved for commercial launch in the country. At present more than 30 companies are manufacturing HIFU device globally. HIFU is approved all most all part of the world such as Asia, Europe and America.<\/p>\n<p style=\"text-align: justify;\"><strong>Read the full PR: <\/strong><a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/high-intensity-focused-ultrasound-hifu-product-analysis-36-nd.php\" target=\"_blank\">http:\/\/www.renub.com\/high-intensity-focused-ultrasound-hifu-product-analysis-36-nd.php<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Report covers High Intensity Focused Ultrasound (HIFU) Product Analysis<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1.<\/strong> EDAP TMS<br \/><strong>2.<\/strong> Sonacare Medical<br \/><strong>3.<\/strong> Haifu<br \/><strong>4.<\/strong> Insightec <br \/><strong>5.<\/strong> Theraclion<br \/><strong>6.<\/strong> Alpinion <br \/><strong>7.<\/strong> Shanghai A&amp;S Co., LTD<br \/><strong>8.<\/strong> Mianyang Sonic Electronic Ltd <br \/><strong>9.<\/strong> Eye Tech Care<br \/><strong>10.<\/strong> FUS Instruments<br \/><strong>11.<\/strong> Image Guided Therapy<br \/><strong>12.<\/strong> Philips Healthcare<br \/><strong>13.<\/strong> Profound Medical Corp<br \/><strong>14.<\/strong> Promedica Bioelectronics<br \/><strong>15.<\/strong> Shenzhen PRO-HIFU Medical Tech. Co., Ltd.<br \/><strong>16.<\/strong> Shenzhen Wikkon<br \/><strong>17.<\/strong> Sonic Concepts<br \/><strong>18.<\/strong> Verasonics<br \/><strong>19.<\/strong> Changjiangyuan Technology Development Co., Ltd<br \/><strong>20.<\/strong> EpiSonica<\/p>\n<p style=\"text-align: justify;\"><strong>Browse Related Reports :<\/strong><br \/><a rel=\"nofollow\" href=\"http:\/\/www.renub.com\/cardiac-maker-analyzer-product-analysis-business-and-marketing-strategy-of-cardiac-maker-companies-1180-p.php\" target=\"_blank\">Cardiac Maker Analyzer Product Analysis, Business &amp; Marketing Strategy of Cardiac Maker Companies<\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About Us<\/strong><\/p>\n<p style=\"text-align: justify;\">Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Renub Research<br \/><strong>Contact Person:<\/strong> Rajat Gupta<br \/><strong>Email:<\/strong> info@renub.com<br \/><strong>Phone:<\/strong> 6783020700<br \/><strong>Address:<\/strong>225 Kristie Ln  <br \/><strong>City:<\/strong> Roswell<br \/><strong>State:<\/strong> GA<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.renub.com\" target=\"_blank\" rel=\"nofollow\">www.renub.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.renub.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=high-intensity-focused-ultrasound-hifu-product-analysis\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Till date more than 100,000 patients have been treated with HIFU therapeutic technology; nearly 25,000 patients alone treated in 2015.&#8221; High-Intensity Focused Ultrasound (HIFU) is an FDA-approved, minimally invasive therapeutic technology with the potential to transform the treatment of many &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/high-intensity-focused-ultrasound-hifu-product-analysis_131087.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-131087","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/131087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=131087"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/131087\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=131087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=131087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=131087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}